Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates


Non-healing corneal erosion treated with epidermal growth factor: case report

    • 6 Accesses

    This is a preview of subscription content, log in to check access.


    1. 1.

      Foerster CG, Cursiefen C, Kruse FE.Persisting corneal erosion under cetuximab (Erbitux) treatment (epidermal growth factor receptor antibody). Cornea 27: 612-614, No. 5, Jun 2008 - Germany

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Cetuximab. React. Wkly. 1209, 11 (2008).

    Download citation


    • Public Health
    • Patient Outcome
    • Congenital Anomaly
    • Cetuximab
    • Actual Body